重症急性脑损伤患者通气试验核心结局指标集:国际德尔菲共识研究结果
该研究遵循COS-STAD/COS-STAP标准开展4轮国际德尔菲研究,旨在为急性脑损伤(ABI)患者的机械通气撤机试验制定国际认可的核心结局指标集(COS)及分层复合终点。来自31个国家的多学科专家组采用9分GRADE量表对候选结局评分,纳入需>70%评为「至关重要」(7-9分)且≤15%评为「不重要」(1-3分)。第1轮78名利益相关者参与,60名完成全部轮次(流失率23.1%);54项结局达成共识,经两次共识会议最终确定涵盖呼吸功能、生存、并发症、功能状态和生活质量5个领域的13项结局,并批准3级分层复合终点:(1)ICU生存,(2)72小时内无再插管,(3)无机械通气存活天数。该COS为ABI通气撤机试验的首个核心结局集,将标准化报告并促进神经重症临床转化。
要点
- 最终COS包含13项结局,覆盖呼吸功能、生存、并发症、功能状态和生活质量5个领域。
- 3级分层复合终点为:(1)ICU生存,(2)72小时内无再插管,(3)无机械通气存活天数。
- 纳入标准为>70%专家组评为「至关重要」(7-9分)且≤15%评为「不重要」(1-3分)。
- NIH卒中量表、脑死亡、无昏迷天数3项结局因疾病特异性或缺乏普适性未获批准。
- 第1轮78名利益相关者参与,60名完成全部轮次,流失率23.1%。
适用人群与场景
- 急性脑损伤(ABI)接受机械通气的重症患者,用于评估撤机相关的通气试验。
诊断标准与关键阈值
- 德尔菲纳入标准:结局需>70%专家组评为「至关重要」(GRADE 9分制中7-9分)且≤15%评为「不重要」(1-3分)。
研究设计与关键结果
- 研究类型:遵循COS-STAD/COS-STAP标准的4轮国际德尔菲共识研究,来自31个国家的多学科专家组参与。
- 第1轮78名利益相关者参与,60名完成全部轮次(流失率23.1%);54项结局达成德尔菲共识。
- 共识会议1将54项结局归入16个类别并选取每类最高分结局;3项结局因疾病特异性(NIH卒中量表)或缺乏普适性(脑死亡、无昏迷天数)未获批准。
- 最终COS包含13项结局,覆盖5个领域:呼吸功能、生存、并发症、功能状态和生活质量。
- 共识会议2批准3级分层复合终点:(1)ICU生存,(2)72小时内无再插管,(3)无机械通气存活天数。
证据类型、等级与局限
- 证据类型:国际德尔菲共识研究(指南/共识)。
- 注册号:COMET Initiative注册号2320。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,广泛采用这13项结局和分层复合终点将标准化报告、实现有意义的证据合成并促进神经重症临床转化。
指南或共识出处
- COMET Initiative注册号2320。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: Clinical research evaluating mechanical ventilation liberation in patients with acute brain injury (ABI) shows substantial outcome heterogeneity, limiting evidence synthesis. We aimed to develop an internationally endorsed core outcome set (COS) and a hierarchical composite endpoint for ventilation trials in neurocritical care.
METHODS: Following COS-STAD/COS-STAP standards, we conducted a 4-round international Delphi study. Candidate outcomes were identified via a scoping review. A multidisciplinary panel from 31 countries scored outcomes using a 9-point GRADE scale. Inclusion required >70% rating as "critical" (score 7-9) and ≤15% as "not important" (1-3). Two consensus meetings were held to categorize outcomes, select representative measures, and ratify a hierarchical composite endpoint.
RESULTS: 78 stakeholders participated in Round 1; 60 completed all rounds (23.1% attrition). Fifty-four outcomes achieved Delphi consensus. At Consensus Meeting 1, these were organized into 16 categories; the highest-scoring outcome per category was selected. Three outcomes were not ratified due to disease-specificity (NIH Stroke Scale) or lack of universal applicability (brain death, coma-free days). The final COS comprised 13 outcomes across 5 domains: respiratory function, survival, complications, functional status, and quality of life. A 3-level hierarchical composite endpoint was ratified at Consensus Meeting 2: (1) intensive care unit survival, (2) no reintubation within 72 hours, and (3) days alive without mechanical ventilation.
CONCLUSION: This study establishes the first COS for ventilation weaning trials in ABI patients. Widespread adoption of these 13 outcomes and the hierarchical composite endpoint will standardize reporting, enable meaningful evidence synthesis, and facilitate clinical translation in neurocritical care.
TRIAL REGISTRATION: Core Outcome Measures in Effectiveness Trials (COMET) Initiative, registration number 2320.
参考来源
- Fong N, Burns G, Phillips J, et al. Consensus on a core outcome set for ventilation trials in critically ill patients with acute brain injury: results of an international Delphi consensus study. Intensive Care Med. 2026. PMID: 42986439. doi:10.1007/s00134-026-08659-0
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。